Pretreatment serum squamous cell carcinoma antigen: A newly identified prognostic factor in early-stage cervical carcinoma

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 111-118

  Duk, J M ^a   Groenier, K H ^a   de Bruijn, H W ^a   Hollema, H ^a   ten Hoor, K A ^a   van der Zee, A G ^a   Aalders, J G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0030030603     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.111     Document Type: Article

References (37)

1. Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197, 1988
2. Petterson F (ed): Twenty-first annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 36:27-130, 1991 (suppl)
3. Gauthier P, Gore I, Shingleton HM, et al: Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol 66:569-574, 1985
4. Figge DC, Tamimi HK: Patterns of recurrence following radical hysterectomy. Am J Obstet Gynecol 140:213-220, 1981
5. Alvarez RD, Soong S-J, Kinney WK, et al: Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 35:130-135, 1989
6. Delgado G, Bundy B, Zaino R, et al: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 38:352-357, 1990
7. Chung CK, Nahhas WA, Stryker VA, et al: Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138:550-556, 1980
8. Baltzer J, Lohe KJ, Köpeke W, et al: Histologic criteria for the prognosis in patients with operated squamous cell carcinoma of the cervix. Gynecol Oncol 13:184-194, 1982
9. Boyce JG, Fruchter RG, Nicastri AD, et al: Prognostic factors in stage I carcinoma of the cervix. Gynecol Oncol 12:154-165, 1981
10. Boyce JG, Fruchter RG, Nicastri AD, et al: Vascular invasion in stage I carcinoma of the cervix. Cancer 53:1175-1180, 1984
11. Burke TW, Hoskins WJ, Heller PB, et al: Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol 26:153-159, 1987
12. Kenter GG, Ansink AC, Heintz APM, et al: Low stage invasive carcinoma of the uterine cervix stage I-IIA. Morphological prognostic factors. Eur J Surg Oncol 14:187-192, 1988
13. Delgado G, Bundy BN, Fowler WC, et al: A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 35:314-320, 1989
14. Fidler IJ, Kripke ML: Metastasis results from pre-existent variant cells within a malignant tumor. Science 217:893-895, 1977
15. Soisson AP, Soper JT, Clarke-Pearson DL, et al: Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 37:390-395, 1990
16. Sagae S, Kuzumaki N, Hisada T, et al: Ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix. Cancer 63:1577-1582, 1989
17. Hayashi Y, Hachisuga T, Iwasaka T, et al: Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node metastasis. Gynecol Oncol 40:147-151, 1991
18. Gullick WJ, Marsden JJ, Whittle N, et al: Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinoma cell lines. Cancer Res 46:285-292, 1986
19. Kato H, Timpani K, Magaya T, et al: Clinical value of SCC antigen, a subfraction of tumor antigen TA-4, in the clinical management of cervical cancer. Jpn J Cancer Clin 31:594-599, 1985 (suppl 6)
20. Duk JM, Groenier KH, de Bruijn HWA, et al: Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol 39:186-194, 1990
21. Duk JM, Aalders JG, Fleuren GJ, et al: Tumor markers CA 125, squamous cell carcinoma antigen and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol 73:661-668, 1989
22. Duk JM, de Bruijn HWA, Groenier KH, et al: Adenocarcinoma of the uterine cervix. The prognostic significance of pretreatment serum CA 125, SCC and CEA levels in relation to clinical and histopathologic tumor characteristics. Cancer 65:1830-1837, 1990
23. Ngan HY, Chan SYW, Wong LC, et al: Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix. Gynecol Oncol 37:260-263, 1990
24. Yazigi R, Munoz AK, Richardson B, et al: Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer. Gynecol Oncol 41:135-138, 1991
25. Rose PG, Baker S, Fournier L, et al: Serum squamous cell carcinoma antigen levels in invasive cervical cancer: Prediction of response and recurrence. Am J Obstet Gynecol 168:942-946, 1993
26. Bolli JN, Doering JR, Bosscher JR, et al: Squamous cell carcinoma antigen: Clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 55:169-173, 1994
27. Scambia G, Benedetti Panici P, Amoroso M, et al: Squamous cell carcinoma antigen: Prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. J Clin Oncol 12:2309-2316, 1994
28. Åvall-Lundqvist EH, Sjövall K, Nilsson BR, et al: Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma. Eur J Cancer 10:1695-1702, 1992
29. Ngan HY, Cheng GTS, Yeung WSB, et al: The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix. Gynecol Oncol 52:63-68, 1994
30. Chou CY, Wang ST, Kuo HC, et al: Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer. Cancer 74:2497-2501, 1994
31. Ferenczy A, Winkler B: Carcinoma and metastatic tumors of the cervix, in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract. New York, NY, Springer Verlag, 1987, pp 218-257
32. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
33. Cox DR: Analysis of Binary Data. London, United Kingdom, Methuen, 1970
34. Beynon DWG, Lopes A, Robertson G, et al: Squamous cell carcinoma antigen: Pretreatment levels as an indicator of advanced or metastatic disease. Int J Gynecol Cancer 4:206-210, 1994
35. Crombach G, Scharl A, Vierbuchen M, et al: Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix. Cancer 63:1337-1342, 1989
36. Vermorken JB: The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review. Int J Gynecol Cancer 3:129-142, 1993
37. Duk JM, van Voorst Vader PC, ten Hoor KA, et al: Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 64:1652-1656, 1989